Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT03219047 · COMPLETED
Trial details
- NCT number
- NCT03219047
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-20
- Primary completion
- 2023-07-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.